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Abstract
Background: Twist, a transcription factor of the basic helix-loop-helix class, is reported to regulate cancer metastasis.
It is known to induce epithelial-mesenchymal transition (EMT). In this study, we evaluated the expression of twist and its
effect on cell migration in hepatocellular carcinoma (HCC).
Methods: We examined twist expression using immunohistochemistry in 20 tissue samples of hepatocellular carcinoma,
and assessed twist expression in HCC cell lines by RT-PCR and Western blot analysis. Ectopic twist expression was
created by introducing a twist construct in the twist-negative HCC cell lines. Endogenous twist expression was blocked
by twist siRNA in the twist-positive HCC cell lines. We studied EMT related markers, E-cadherin, Vimentin, and N-
cadherin by Western blot analysis. Cell proliferation was measured by MTT assay, and cell migration was measured by
in vitro wound healing assay. We used immunofluorescent vinculin staining to visualize focal adhesion.
Results: We detected strong and intermediate twist expression in 7 of 20 tumor samples, and no significant twist
expression was found in the tumor-free resection margins. In addition, we detected twist expression in HLE, HLF, and
SK-Hep1 cells, but not in PLC/RPF/5, HepG2, and Huh7 cells. Ectopic twist-expressing cells demonstrated enhanced cell
motility, but twist expression did not affect cell proliferation. Twist expression induced epithelial-mesenchymal transition
together with related morphologic changes. Focal adhesion contact was reduced significantly in ectopic twist-expressing
cells. Twist-siRNA-treated HLE, HLF, and SK-Hep1 cells demonstrated a reduction in cell migration by 50, 40 and 18%,
respectively.
Conclusion: Twist induces migratory effect on hepatocellular carcinoma by causing epithelial-mesenchymal transition.
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Background
Hepatocellular carcinoma (HCC) is one of the most fatal
cancers, especially in eastern Asia [1-3]. Despite the recent
advances in diagnosis and treatment of HCC, the mortal-
ity rate of HCC remains high [2,3]. Many resources have
been devoted to prevention through better understanding
of the causes and finding cures for HCC. Viral infections
that cause chronic hepatitis and progressive liver cirrhosis
are known to cause HCC [1,4]. Although new therapies
for chronic hepatitis have been developed, the number of
HCC patients has not declined [5,6].
The treatment of HCC is dependent on the tumor stage at
the time of diagnosis. Potentially curative hepatic resec-
tion and partial ablation therapy are reserved for patients
in the earlier stages of HCC [7,8]. A major reason for poor
prognosis of HCC is the recurrence and metastasis after
surgery or ablation therapy. Therefore, prevention of
metastasis is important for HCC therapy [9].
Metastasis is a complex process and various factors are
involved in each step of metastasis [10]. Recent studies
suggest that numerous genes and proteins involved in
essential roles during embryonic development are
mutated or aberrantly expressed in different cancers [11-
13]. Epithelial-mesenchymal transition (EMT) is a charac-
teristic of the most aggressive metastatic cancer cells [14-
19]. Cells that undergo EMT morphogenesis switch from
an apical-basolateral, polarized epithelial phenotype to a
spindle-shaped, fibroblast-like mesenchymal phenotype.
In their natural state, epithelial cells exist as tight cell clus-
ters that maintain cell-cell or cell-to-matrix contacts,
whereas mesenchymal cells are loosely organized, unpo-
larized cells with reduced adhesion and enhanced migra-
tory tendencies. A key feature in the initiation and
execution of EMT is the down regulation of E-cadherin
expression [14-16]. Several mechanisms that down-regu-
late E-cadherin expression have been reported recently
[20-22].
A transcriptional factor involved in down-regulation of E-
cadherin, twist, has been shown to play a crucial role in
carcinoma metastasis. Microarray analysis revealed that
twist is predominantly expressed in metastatic cancers
[23-25]. Furthermore, a loss of twist expression prevents
the intravasation of metastatic tumor cells into the blood
circulation [25]. Twist-enhanced cancer metastasis
includes breast cancer, gastric cancer, and HCC
[24,26,27].
Therefore, we conducted the present study to investigate
the role of twist in cell migration of HCC cells and its role
in metastasis.
Methods
HCC tissues and immunohistochemistry
Twenty patients including 12 men with ages ranging from
53 to 77 years (average age, 64 years) and eight women
with ages ranging from 54 to 82 years (average age, 64
years) at the time of hepatic resection were included in
this study. HCC tissues along with adjacent liver tissues
were used for analysis. We obtained informed consent
from all donors of liver tissue samples, as per the institu-
tional guidelines, and the study was approved by the
Research Ethics Committee of Okayama University.
We performed immnunohistochemistry on formalin-
fixed paraffin sections. The sections were dewaxed and
dehydrated. After rehydration, endogenous peroxidase
activity was blocked for 30 min using a methanol solution
containing 0.3% hydrogen peroxide. After antigen
retrieval in citrate buffer, we blocked the sections over-
night at 4°C. The sections were probed with goat polyclo-
nal antibody (Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA). The primary antibody was detected using a
biotinylated anti-goat antibody (Dako Japan, Tokyo,
Japan). The signal was amplified by avidin-biotin com-
plex formation and developed using diaminobenzidine
followed by counterstaining with hematoxylin. Next, the
samples were dehydrated in alcohol and xylene and
mounted onto glass slides. The sections were scored for
twist expression using a four-titer scale: 0, negative; 1,
weak signal; 2, intermediate signal; and 3, strong signal
[28]. Two observers, who were blinded to the samples,
independently scored the sections. We reviewed all dis-
crepancies in the scoring process and reached a consensus.
Cell lines and cell culture
We obtained the human HCC cell lines, HLE, HLF, and
Huh7 from the Health Science Research Resources Bank
(Osaka, Japan), and SK-Hep1, PLC/PRF/5 (PLC), and
HepG2 cell lines from the American Type Culture Collec-
tion (Manassas, VA, USA). We maintained the cells in
Dulbecco's modified Eagle's medium (Invitrogen,
Carlsbad, CA, USA). Media were supplemented with 10%
heat-inactivated fetal bovine serum [(FBS), Sigma, St.
Louis, MO, USA], 1% nonessential amino acid (Sigma),
1% sodium pyruvate (Sigma), and 1% penicillin/strepto-
mycin solution (Sigma). We cultured the cells at 37°C in
a humidified atmosphere of 5% CO2 and 95% air. Cells
were quiesced using restricted serum conditions of 0.1%
dialyzed FBS at subconfluence for 24 h prior to the exper-
iments.
Determination of twist expression levels in HCC cell lines
We determine twist expression levels in HCC cell lines by
reverse transcriptase-polymerase chain reaction (RT-PCR).
Total RNA was isolated from HCC cell lines using TRIzol™
reagent (Invitrogen). Reverse transcription was performedBMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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with extracted RNA using random primers and RiverTra
Ace™ (Toyobo, Osaka, Japan) reverse transcriptase. Sense
oligonucleotide primer (5'-CGCCCCGCTCTTCTCCTCT-
3') and antisense primer (5'-GACTGTCCATTTTCTCCT-
TCTCTG-3') were designed using a primer select program
in the Lasergene™ software (DNAStar, Madison, WI, USA)
based on the published sequence of twist (Gene Bank
accession no. NM000474). All PCR reactions were per-
formed under the following conditions. The reaction mix-
ture consisted of 100 ng template DNA, 3.2 pmol forward
primer, 3.2 pmol reverse primer, 0.4 μL deoxynucleoside
triphosphates (25 mM each), 2.5 U pfu turbo DNA
polymerase (Stratagene, LaJolla, CA, USA), and 5.0 μL
10× pfu reaction buffer. The volume of the reaction mix-
ture was adjusted to 50 μL with sterile distilled H2O. PCR
amplification was performed in an iCycler™ (Bio-Rad,
Hercules, CA, USA) using the following conditions: cycle
1, 95°C for 2 min; cycle 2–30, 95°C for 30 s, 56°C for 30
s, and 72°C for 90 s and a final elongation step of 72°C
for 10 min.
Immunoblot analysis
We grew the cells to confluence in 6-well tissue culture
plastic dishes. The cells were washed two times with cold
PBS, lysed with 150 μL of sample buffer (100 mM Tris-
HCl pH6.8, 10% glycerol, 4% sodium dodecyl sulfate
[SDS], 1% bromophenol blue, 10% β-mercaptoethanol),
resolved by SDS-polyacrylamide gel electrophoresis
(PAGE), and finally transferred to an Immobilon-P™ pol-
yvinylidene difluoride membrane (Millipore Corpora-
tion, Bedford, MA, USA). We blocked the membranes
using Tris-buffered saline with Tween 20 (Sigma) (TBS-T)
buffer containing 1% bovine serum albumin for 1 h. Next,
we incubated the membranes with anti-twist antibody
(Santa Cruz Biotechnology Inc.), anti-E-cadherin anti-
body (Cell Signaling Technology, Denvers, MA, USA),
anti-vimentin antibody (Santa Cruz Biotechnology Inc.),
anti-N-cadherin antibody (Cell Signaling Technology),
and anti-α-actin antibody (Sigma). We washed the mem-
branes three times with TBS-T and probed with horserad-
ish peroxidase-conjugated secondary antibody before
developing them using an ECL Western blotting detection
system (Amersham Biosciences, Piscataway, NJ, USA) by
enhanced chemiluminescence.
Growth proliferation assay
Cell proliferation was assessed by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. In
brief, we plated the cells in 96-well tissue culture plastic
dishes at a concentration of 104 cells/mL. After 24 h of
quiescence, the cells were cultured for 72 h with or with-
out 10% FBS. At the end of the treatment, 10 μL MTT (5
mg/mL in phosphate buffered saline) was added to each
well and incubated for an additional 4 h at 37°C. The
colored formazan product was then dissolved in 100 μL of
DMSO. We evaluated the activity of the mitochondria,
reflecting cellular growth and viability, by measuring the
optical density at 570 nm using a microplate reader (Bio-
Rad).
Cell migration assay
We assessed cell migration by determining the ability of
the cells to move into an acellular space in a two-dimen-
sional in vitro "wound healing assay" [29]. In brief, cells
were grown to confluence in 6-well tissue culture plastic
dishes to a density of approximately 5 × 106 cells/well.
After 24 h of quiescence, the cells were denuded by drag-
ging a rubber policeman (Fisher Scientific, Hampton, NH,
USA) through the center of the plate. Cultures were rinsed
with PBS and replaced with fresh quiescent medium alone
or containing 10% FBS, following which the cells were
incubated at 37°C for 24 h. Photographs were taken at 0
and 24 h, and the relative distance traveled by the cells at
the acellular front was measured.
Cloning and transfection of Twist
We obtained human twist cDNA by PCR-based cloning
from a normal human placental cDNA library (Takara Bio
Inc., Otsu, Japan). In brief, cDNA was amplified by PCR
using sense and antisense primers and Pfu Turbo DNA
polymerase (Stratagene) and cloned into PCR II TA clon-
ing vector (Invitrogen). The size of the PCR product was
~750 bp. After confirming the sequence, the twist cDNA
was subcloned into pcDNA 3.1 expression vector (Invitro-
gen) downstream from a cytomegalovirus (CMV) pro-
moter. Twist and/or CAT (control) constructs were
transfected into the HCC cell lines using Superfect™ trans-
fection reagent (Qiagen, Hilden, Germany), as per the
manufacture's instructions. After transfection, the cells
were incubated for 24–48 h and utilized for the following
experiments.
Morphological analysis and immunofluorescence staining
We plated cells in 2 mL media in 6-well tissue culture plas-
tic dishes at a concentration of 105 cells/mL. After 48 h of
transfection, we observed the morphology under a phase-
contrast microscope. For immunofluorescence staining,
cells were seeded on Lab-Tek™ slide chamber (Nunc
Rochester, NY, USA). After 24 h incubation, cells were
fixed for 20 min in 3% freshly hydrolyzed paraformalde-
hyde in PBS at room temperature. Cells were first stained
with rhodamine-phaloidin (Invitrogen) and then with an
anti-vinculin antibody (Sigma) for 30 min at room tem-
perature, washed three times with PBS, and visualized
using Oregon Green conjugated secondary antibody (Inv-
itrogen). Photographs were taken using a fluorescence
microscope (BX51, Olympus, Tokyo, Japan) equipped
with a digital image capturing system (DP50, Olympus).
The numbers of focal adhesion complexes were deter-
mined by vinculin staining.BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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Gene silencing with small interfering RNA (siRNA)
We obtained siRNA duplexes targeting twist sequences
and control (Silencer Negative™) from Applied Biosys-
tems (Foster City, CA, USA). We transfected the siRNAs
into the cells using RNAiFect™ transfection reagent (Qia-
gen), and incubated the cells for 48 h before the analysis.
The interference of twist protein expression was con-
firmed by immunoblot analysis using anti-twist antibody.
Cell migration assay was performed, as described above.
Results
Twist-expression in HCC tissues
Immunohistochemical analysis revealed twist expression
in both cytoplasm and nuclei in HCC tissues with
enhanced expression in the cytoplasm in most cases. Rep-
resentative images of twist-positive HCC and the corre-
sponding tumor-free section are shown in Figure 1. Strong
(Score 3) and intermediate (Score 2) twist expression was
detected in 7 of 20 tumor samples (Figure 1 and Table 1),
while no (Score 0) significant twist expression was found
in tumor-free resection margins. We observed no signifi-
cant difference in clinicopathologic features in high twist
expressing samples compared with low twist expressing
samples (Table 1).
Twist expression in HCC cell lines correlated cell character
To evaluate twist expression in various HCC cell lines, we
assessed twist mRNA and protein expressions by RT-PCR
and immnunoblot analysis, respectively (Figures 2A, B).
Twist mRNA was expressed in HLE, HLF, and SK-Hep1
cells, while no detectable twist mRNA was found in PLC,
HepG2, and Huh7 cells.
We assessed cell proliferation and migration activities in
the HCC cell lines. Average basal cell proliferative activi-
ties of twist-positive and twist-negative HCC cell lines
were 0.86 ± 0.04 and 0.78 ± 0.04, respectively (Figure 2C).
FBS-induced cell proliferative activities of twist-positive
and twist-negative HCC cell lines were 2.34 ± 0.22 and
1.67 ± 0.07, respectively (Figure 2C). Average basal cell
migration activities of twist-positive and twist-negative
HCC cell lines were 0.79 ± 0.08 and 0.32 ± 0.03, respec-
tively (Figure 2D). FBS-induced cell migration activities of
twist-positive HCC cell lines and twist-negative HCC cell
lines were 1.26 ± 0.08 and 0.45 ± 0.02, respectively (Fig-
ure 2D).
Twist expression did not stimulate cell proliferation in 
HCC cell lines
To investigate the effect of ectopic twist expression, we
introduced a twist construct into twist-negative HCC cell
lines. As shown in Figure 3A, introduction of a twist con-
Twist expression in HCC tissue and its adjacent liver tissue Figure 1
Twist expression in HCC tissue and its adjacent liver tissue. Twist expression was assessed by immunohistochemical 
staining in a human HCC tissue (left panel) and corresponding tumor-free section (right panel). Photographs were taken using 
a light microscope (BX51, Olympus) equipped with a digital image capturing system (DP50, Olympus). Shown are the repre-
sentative images of twist expressing a HCC tissue and its corresponding tumor-free section.BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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struct induced expression of the twist protein. Cell growth
proliferation was assessed by MTT assay (Figure 3B). In all
three twist-negative HCC cell lines, twist expression did
not have any effect on cell proliferation.
Twist expression enhanced cell migration in HCC cell lines
To examine the effect of ectopic twist expression on HCC
cell lines, we performed an in vitro wound healing assay.
This assay is commonly used for assessing the effect of
pro- and anti-migratory agents on cultured cells [30].
Twist expression significantly enhanced cell migration of
HCC cell lines (Figure 3C). The twist-induced cell migra-
tion activities were 1.8-, 1.5-, and 3.6-fold in PLC, HepG2,
and Huh7 cells, respectively.
Induction of twist expression promotes EMT in HCC cell 
lines
To investigate the effect of twist expression, we assessed
the expression of EMT markers by immunoblot analysis
(Figure 4). The expression of the epithelial marker, E-cad-
herin, was down-regulated, while the expression of mes-
enchymal markers, vimentin and N-cadherin, were up-
regulated in twist-induced cells.
Twist expression induces morphological change and 
reduces focal adhesion in HCC cell lines
To elucidate the mechanisms involved in increased migra-
tion, we assessed the morphology of twist expressing cells.
We utilized immunofluorescence double staining for
actin cytoskeleton and focal adhesion to examine whether
twist expression mediates a change in cell shape, stress
fiber organization, and/or focal adhesion. Phase-contrast
microscopy (data not shown) and immunofluorescence
staining demonstrated that twist induced transformation
from polarized, tight contact, rectangular-shape cell mor-
phology to scattered, asteroid or fibroblast-like cell mor-
phology. Twist expressing cells had reduced actin filament
(Figure 5A). Vinculin staining demonstrated that twist
expression markedly reduced vinculin localization with
respect to focal contact in PLC cells (Figure 5A). Quantita-
tive analysis of focal adhesion revealed that twist expres-
sion diminished focal adhesion by 52 ± 7%, 61 ± 6%, and
52 ± 5% in PLC, HepG2, and Huh7 cells, respectively (Fig-
ure 5B).
siRNA against twist reduced cell migration activity in twist-
positive HCC cell lines
To examine the effect of twist suppression in twist-positive
HCC cell lines, siRNA was used. siRNA blocked twist
expression in twist-positive HCC cell lines (Figure 6A).
Twist siRNA inhibited cell migration by 50 ± 11%, 44 ±
10%, and 18 ± 14% in HLE, HLF, and SK-Hep1, respec-
tively (Figure 6B).
Discussion
In the current study, we demonstrate that twist induces
pro-migratory effects in HCC cell lines by inducing EMT.
Cancers such as HCC are multi-step processes associated
with changes in gene expressions involved in cell prolifer-
ation, invasion, and metastasis. With recent advances in
ablation techniques and hepatic resection, there have
been marked improvements in local tumor control for
HCC treatment [7,8]; however, patients with metastatic
HCC still have a poor prognosis. Management of metasta-
sis will therefore contribute to the improvement of prog-
nosis for the HCC patient.
Various metastasis-related genes have been reported for
HCC and other cancers. Twist, a transcription factor of the
basic helix-loop-helix class, was identified as one of the
most up-regulated genes in a metastatic murine breast
tumor by microarray analysis [24]. Twist was originally
reported as a master regulator of embryonic morphogen-
esis [31-33]. Recent studies revealed that twist-induced
EMT enhances tumor metastasis [24,34]. It is reported
that twist expression is elevated in invasive lobular carci-
noma in human breast cancer [35]. Another study dem-
onstrated up-regulation of twist in a diffuse-type gastric
carcinoma in contrast to a well-differentiated intestinal
carcinoma [36].
We first assessed twist expression in HCC cell lines and
HCC tissues (Figures 1, 2A, B and Table 1) and found that
some of these cell lines and tissues expressed twist protein
or mRNA. In HCC tissue samples expressing twist, there
were no significant clinicopathologic finding (Table 1).
The HCC tissues were collected from HCC cases that
could be operated on; thus, no case had distant metasta-
sis. Immunohistochemical observations revealed that
twist expression occurred in both cytoplasm and nuclei of
HCC tissues. It is reported that high-level nuclear twist
expression is associated with distant metastasis of other
cancers [37]. In most HCC tissue samples, twist was
Table 1: Twist expression levels and clinicopathologic features.
Twist expression score 0 (n = 7) 1 (n = 6) 2 (n = 6) 3 (n = 1)
pTNM stage
Stage I 1 0 1 1
S t a g e  I I 2240
Stage IIIA 4 4 1 0
Stage IIIB 0 0 0 0
S t a g e  I V 0000
Distant metastasis
M 0 7661
M 1 0000
Portal vein invasion
absence 7 3 4 1
presence 3 3 2 0BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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Twist expression in HCC cell lines Figure 2
Twist expression in HCC cell lines. A, B. Cells were grown to confluence in 6-well tissue culture plastic dishes. Total RNA 
was extracted from various HCC cell lines. mRNA expression of twist and GAPDH were determined by RT-PCR using a twist-
specific primer set (A). Shown are representative gel pictures of three independent studies. Twist protein expression was ana-
lyzed by SDS-PAGE and immunoblot using anti-twist antibody (B). Immunoblotting for α-actin expression levels was used to 
verify equal loading of cellular protein. Normal liver samples were used to determine twist expression level in nonmalignant tis-
sue. Shown are representative blots of more than three independent studies. C, D. Cells were plated and quiesced for 24 h in 
DME with 0.1% dialyzed FBS. Later the cells were cultured with (black bars) or without (clear bars) 10% FBS. Cell proliferation 
(C) and cell migration activities (D) were assessed as described in Materials and Method. All results are expressed as a ratio to 
non-treated HLE cells. The data are the mean ± SEM of at least three independent studies each performed in triplicate.
￿
￿
￿
￿BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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Effect of ectopic twist expression Figure 3
Effect of ectopic twist expression. CMV-driven eukaryotic expression constructs for CAT (control) and twist were intro-
duced into PLC, HepG2, and Huh7 cells using Superfect™ chemical transfection reagent. A. After a 48-h incubation period, 
cells were lysed. Equal amounts of protein were analyzed by SDS-PAGE and immunoblotted with anti-twist and anti-α-actin 
antibodies. Shown are representative blots of more than three independent studies. B, C. After a 24-h incubation period, cells 
were quiesced for 24 h in DME with 0.1% dialyzed FBS. Then cells were cultured with 10% FBS. Cell proliferation (B) and cell 
migration activities (C) were assessed as described in Materials and Method. All results are expressed as a ratio to control 
CAT cDNA transfected PLC (CAT; clear bars, twist; black bars). The data are the mean ± SEM of at least three independent 
studies each performed in triplicate. Statistical analysis was performed by Student's t-test: **P < 0.01; n.s., not significant (vs 
CAT cDNA transfected cells).
￿
￿
￿BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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expressed predominantly in the cytoplasm, probably
because these cases did not have distant metastasis. Fur-
ther studies with more cases, including those with distant
metastasis, are necessary to evaluate the relationship
between twist expression and clinical features of HCC.
Twist expression in other carcinomas correlates with HCC
metastasis [26]. In this report, the researchers focused on
EMT and a decrease in E-cadherin expression caused by
twist expression. E-cadherin is a key regulatory molecule
involved in cell-cell adhesion. In the current study, we
focused on the cell-substratum contact that regulates cell
migration with respect to metastasis.
We classified six HCC cell lines into two groups: twist-pos-
itive and twist-negative (Figures 2A, B). In accordance
with previous reports, twist expressing cells were classified
in nondifferentiated carcinoma cell lines [38-42]. Mor-
phologic observation also showed that twist expressing
cells were nondifferentiated or had mesenchymal-like
morphology (data not shown).
Cell proliferation and migration activities were assessed
and compared between the two groups of HCC cell lines
(Figures 2C, D). Twist-positive HCC cell lines showed
higher cell migration activity compared with twist-nega-
tive cell lines. On the other hand, no difference was
observed in cell proliferation activity of the twist-positive
and twist negative HCC cell lines.
To elucidate the effect of twist expression in HCC cells,
twist cDNA was introduced into twist-negative HCC cell
lines. Ectopic expression of the twist  gene successfully
induced twist protein expression in twist-negative cell
lines (Figure 3A). Twist expression did not increase cell
proliferation in these cells (Figure 3B); however, cell
migration activities increased in the three cell lines (Figure
3C). In agreement with a former report [26], these results
demonstrated that twist expression may regulate cell
migration in HCC.
Previous research has demonstrated that there are similar-
ities between metastatic cancer cells and embryonic stem
cells [43]. In epithelial cells, high expression of twist is
associated with a loss in epithelial markers, including E-
cadherin and β-catenin [24]. Instead, these cells express
mesenchymal markers, including vimentin and N-cad-
herin. Because E-cadherin is essential for epithelial cell-
cell adhesion, loss of E-cadherin expression would likely
promote cancer metastasis. EMT causes aggressive behav-
ior in HCC cell lines. Consistent with other reports,
ectopic twist expression resulted in EMT in HCC cell lines
(Figure 4).
Morphologic observations of HCC cell lines showed epi-
thelial-like, well-differentiated carcinoma, as in PLC (Fig-
ure 5A), HepG2, and Huh7 (data not shown); these are all
twist-negative HCC cell lines. On the other hand, undif-
ferentiated carcinomas, such as HLE, HLF, SK-Hep1, are
twist-positive HCC cell lines. Ectopic introduction of twist
converted the characteristics of well-differentiated HCC
cell lines to resemble those of undifferentiated cell types.
Observing the morphology of cells with ectopic twist
expression, we hypothesized that cell-substratum contact
is reduced in these cells. Vinculin staining was utilized to
visualize the focal adhesion contact (Figure 5A). In all,
three twist-negative HCC cells, ectopic twist expression
decreased the number of focal adhesion contacts by more
than 50% (Figure 5B).
Focal adhesions are known to induce integrin signaling,
which activate cell migration. Integrin signaling pathway
modulates the activity of Rho family GTPases, such as
cdc42, Rac1, and RhoA [44]. These proteins are key regu-
lators of the actin cytoskeleton, which is involved in
dynamic cellular activity. Cdc42 and Rac1 stimulate the
formation of two types of membrane protrusions, known
as filopodia and lamellipodia [44,45]. RhoA activation
leads to the formation of focal adhesion and contractile
bundles of actin and myosin, known as stress fibers [44],
and increases levels of vinculin presenting focal adhesions
[46]. In contrast, a decrease in RhoA activation may
EMT marker in twist expressed cell Figure 4
EMT marker in twist expressed cell. CMV-driven 
eukaryotic expression constructs for CAT (control) and 
twist were introduced into PLC cells using Superfect™ 
chemical transfection reagent. After a 48-h incubation 
period, cells were lysed. Equal amounts of protein were ana-
lyzed by SDS-PAGE and immunoblotted with anti-twist, anti-
E-cadherin, anti-vimentin, anti-N-cadherin, and anti-α-actin 
antibodies. Shown are representative blots of more than 
three independent studies.BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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Focal adhesion staining of twist expressed cells Figure 5
Focal adhesion staining of twist expressed cells. CAT (control) and twist cDNAs were introduced in PLC, HepG2, and 
Huh7 cells using Superfect™ chemical transfection reagent. After a 48-h incubation period, cells were fixed. Focal adhesion 
complexes were visualized by immunofluorescence staining of vinculin (green), as described in Materials and Method. Actin 
stress fibers were detected with rhodamine-phaloidin (red). A. Representative fields from three independent experiments in 
PLC are shown. B. Focal adhesion complexes in each cell were counted. All results are expressed as a ratio to control (CAT) 
cDNA transfected PLC (CAT; clear bars, twist; black bars). The data are the mean ± SEM of at least three independent studies 
each performed in triplicate. Statistical analysis was performed by Student's t-test: **P < 0.01 (vs CAT cDNA transfected cells).BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
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Effect of gene silencing using twist siRNA on cell migration Figure 6
Effect of gene silencing using twist siRNA on cell migration. A. After treatment with twist siRNA duplexes, twist pro-
tein expression was analyzed by SDS-PAGE and immunoblot using anti-twist antibody. Immunoblotting for α-actin expression 
levels was used to verify equal loading of cellular protein. Shown are representative blots of more than three independent stud-
ies. B. After treatment with twist siRNA duplexes, cell migration assay was performed, as described in Materials and Methods. 
All results are expressed as a ratio to control siRNA treated HLE (control siRNA; clear bars, twist siRNA; black bars). The 
data are mean ± SEM of at least three independent studies, each performed in triplicate. Statistical analysis was performed by 
Student's t-test: *P < 0.01; n.s., not significant (vs control siRNA treated cells).BMC Cancer 2009, 9:240 http://www.biomedcentral.com/1471-2407/9/240
Page 11 of 12
(page number not for citation purposes)
explain our observed decrease in cytoskeletal F-actin and
vinculin expression observed in twist-induced HCC cell
lines. In the current study, we did not investigate the
mechanisms of inactivation of RhoA protein through
overexpression of twist.
To evaluate the role of twist expression in regulating cell
migration in HCC cell lines, we used twist siRNA. Twist-
positive HCC cell lines were treated with twist siRNA.
Twist siRNA successfully blocked the twist expression in
twist-positive HCC cell lines (Figure 6A). Blocking of
endogenous twist resulted in a decrease in cell migration
related activities of HCC cell lines (Figure 6B). These
results emphasize that twist regulates cell migration in
HCC cells.
Conclusion
In the current study, we demonstrated that twist expres-
sion regulates cell migration in HCC by decreasing cell-
substratum adhesion. However, further studies are
required to elucidate the mechanisms of decrease in focal
adhesion. Twist and related molecules could be a possible
therapeutic target for metastatic HCC.
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